|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| 12th Annual FT Pharmaceutical Conference 2001 | ||||||||||||||||
| July 12, 2001 | ||||||||||||||||
|
Financial Times, Four Seasons Hotel - London 2001 - 11 - 05 Please visit our website at: www.ftconferences.com/pharma |
||||||||||||||||
| Organized by: | Financial Times Conferences | |||||||||||||||
| Invited Speakers: | KEYNOTE SPEAKER Dr Henry A. McKinnell Chairman & Chief Executive Officer Pfizer Inc CONFIRMED SPEAKERS INCLUDE Dr George Poste Chief Executive Officer Health Technology Networks Dr William A. Haseltine, Ph.D. Chairman & Chief Executive Officer Human Genome Sciences, Inc Dr Silvano Fumero Senior Executive Vice President of Research & Pharmaceutical Development Serono SA Dr Paul Herrling Head of R&D Novartis Dr John C. Lechleiter Executive Vice President, Pharmaceutical Products and Corporate Development Eli Lilly and Company Dr Harvey E. Bale, Jr Director General International Federation of Pharmaceutical Manufacturers Associations (IFPMA) Bruno Angelici Executive Vice President Europe, Japan, Asia-Pacific & R.o.W AstraZeneca PLC Eduardo Sanchiz Executive Director, Global e-Commerce Eli Lilly & Company Dr David L Heyman Executive Director Communcable Diseases World Health Organisation ........and many more. Please visit our website at www.ftconferences.com/pharma |
|||||||||||||||
| Deadline for Abstracts: | 2001 - 11 - 05 | |||||||||||||||
| Registration: | Early Bird offer at £950.00 (exclu VAT) - Until 10th September 2001. Thereafter price per delegate will be £1,050 (exclud VAT). |
|||||||||||||||
| E-mail: | roni.taha@ft.com | |||||||||||||||
| Posted by: | Roni Taha | |||||||||||||||
| Host: | newsgate.ft.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||